Israel Englander Nex Immune, Inc. Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.26 - $0.47 $46,001 - $83,156	-176,928 Reduced 74.8%	59,593 $16,000
Q1 2023 May 15, 2023	SELL	$0.3 - $0.6 $80,739 - $161,478	-269,131 Reduced 53.22%	236,521 $90,000
Q4 2022 Feb 14, 2023	BUY	$0.21 - $18.5 $72,286 - $6.37 Million	344,223 Added 213.23%	505,652 $123,000
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $11,927 - $347,882	-19,879 Reduced 10.96%	161,429 $90,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $6.04M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.